Opinion
Video
Author(s):
Multiple studies analyzing considerations for transplant-ineligible patients receiving second-line treatment with CAR T-cell therapy are discussed by key opinion leaders.
Video content above is prompted by the following:
2 Commerce Drive
Cranbury, NJ 08512